nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP2C19—Prednisone—ankylosing spondylitis	0.088	0.23	CbGbCtD
Thioridazine—CYP2E1—Dexamethasone—ankylosing spondylitis	0.0876	0.229	CbGbCtD
Thioridazine—CYP2C8—Dexamethasone—ankylosing spondylitis	0.0655	0.171	CbGbCtD
Thioridazine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0549	0.143	CbGbCtD
Thioridazine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0457	0.119	CbGbCtD
Thioridazine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0418	0.109	CbGbCtD
Thioridazine—Menstruation irregular—Prednisolone—ankylosing spondylitis	0.0156	0.0253	CcSEcCtD
Thioridazine—Systemic lupus erythematosus—Triamcinolone—ankylosing spondylitis	0.0143	0.0232	CcSEcCtD
Thioridazine—Menstruation irregular—Triamcinolone—ankylosing spondylitis	0.0143	0.0232	CcSEcCtD
Thioridazine—Menstruation irregular—Methylprednisolone—ankylosing spondylitis	0.0143	0.0232	CcSEcCtD
Thioridazine—Menstruation irregular—Betamethasone—ankylosing spondylitis	0.013	0.0211	CcSEcCtD
Thioridazine—Menstruation irregular—Dexamethasone—ankylosing spondylitis	0.013	0.0211	CcSEcCtD
Thioridazine—Menstruation irregular—Prednisone—ankylosing spondylitis	0.0113	0.0184	CcSEcCtD
Thioridazine—Sudden death—Methotrexate—ankylosing spondylitis	0.0102	0.0166	CcSEcCtD
Thioridazine—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.00901	0.0146	CcSEcCtD
Thioridazine—Eruption—Methotrexate—ankylosing spondylitis	0.00852	0.0138	CcSEcCtD
Thioridazine—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.00819	0.0133	CcSEcCtD
Thioridazine—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.00819	0.0133	CcSEcCtD
Thioridazine—Dermatitis contact—Triamcinolone—ankylosing spondylitis	0.00784	0.0127	CcSEcCtD
Thioridazine—Amenorrhoea—Prednisone—ankylosing spondylitis	0.00713	0.0116	CcSEcCtD
Thioridazine—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.00711	0.0115	CcSEcCtD
Thioridazine—Dermatitis contact—Dexamethasone—ankylosing spondylitis	0.00711	0.0115	CcSEcCtD
Thioridazine—Hepatotoxicity—Methotrexate—ankylosing spondylitis	0.00678	0.011	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00595	0.00965	CcSEcCtD
Thioridazine—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00561	0.0091	CcSEcCtD
Thioridazine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00548	0.00888	CcSEcCtD
Thioridazine—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00547	0.00886	CcSEcCtD
Thioridazine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00546	0.00886	CcSEcCtD
Thioridazine—Lethargy—Dexamethasone—ankylosing spondylitis	0.00533	0.00865	CcSEcCtD
Thioridazine—Lethargy—Betamethasone—ankylosing spondylitis	0.00533	0.00865	CcSEcCtD
Thioridazine—Sweating increased—Prednisolone—ankylosing spondylitis	0.00527	0.00855	CcSEcCtD
Thioridazine—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.0051	0.00827	CcSEcCtD
Thioridazine—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.0051	0.00827	CcSEcCtD
Thioridazine—Asthma—Triamcinolone—ankylosing spondylitis	0.00498	0.00807	CcSEcCtD
Thioridazine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00497	0.00806	CcSEcCtD
Thioridazine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00497	0.00806	CcSEcCtD
Thioridazine—Weight increased—Prednisolone—ankylosing spondylitis	0.00493	0.00799	CcSEcCtD
Thioridazine—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00492	0.00797	CcSEcCtD
Thioridazine—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00485	0.00786	CcSEcCtD
Thioridazine—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00484	0.00784	CcSEcCtD
Thioridazine—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00469	0.0076	CcSEcCtD
Thioridazine—Lethargy—Prednisone—ankylosing spondylitis	0.00464	0.00753	CcSEcCtD
Thioridazine—Weight increased—Triamcinolone—ankylosing spondylitis	0.00453	0.00734	CcSEcCtD
Thioridazine—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00452	0.00733	CcSEcCtD
Thioridazine—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00444	0.00721	CcSEcCtD
Thioridazine—Sweating increased—Dexamethasone—ankylosing spondylitis	0.0044	0.00713	CcSEcCtD
Thioridazine—Sweating increased—Betamethasone—ankylosing spondylitis	0.0044	0.00713	CcSEcCtD
Thioridazine—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00433	0.00702	CcSEcCtD
Thioridazine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00433	0.00702	CcSEcCtD
Thioridazine—Weight increased—Dexamethasone—ankylosing spondylitis	0.00411	0.00666	CcSEcCtD
Thioridazine—Weight increased—Betamethasone—ankylosing spondylitis	0.00411	0.00666	CcSEcCtD
Thioridazine—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.00403	0.00653	CcSEcCtD
Thioridazine—Lethargy—Methotrexate—ankylosing spondylitis	0.00388	0.00629	CcSEcCtD
Thioridazine—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00387	0.00627	CcSEcCtD
Thioridazine—Sweating increased—Prednisone—ankylosing spondylitis	0.00383	0.00621	CcSEcCtD
Thioridazine—Erythema—Prednisolone—ankylosing spondylitis	0.00377	0.00611	CcSEcCtD
Thioridazine—Weight increased—Prednisone—ankylosing spondylitis	0.00358	0.0058	CcSEcCtD
Thioridazine—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00356	0.00577	CcSEcCtD
Thioridazine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00355	0.00576	CcSEcCtD
Thioridazine—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00355	0.00576	CcSEcCtD
Thioridazine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00348	0.00565	CcSEcCtD
Thioridazine—Erythema—Triamcinolone—ankylosing spondylitis	0.00347	0.00562	CcSEcCtD
Thioridazine—Erythema—Methylprednisolone—ankylosing spondylitis	0.00346	0.00561	CcSEcCtD
Thioridazine—Angioedema—Prednisolone—ankylosing spondylitis	0.00345	0.00559	CcSEcCtD
Thioridazine—Asthma—Methotrexate—ankylosing spondylitis	0.00329	0.00533	CcSEcCtD
Thioridazine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00325	0.00528	CcSEcCtD
Thioridazine—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00323	0.00524	CcSEcCtD
Thioridazine—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00323	0.00524	CcSEcCtD
Thioridazine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00317	0.00514	CcSEcCtD
Thioridazine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00316	0.00513	CcSEcCtD
Thioridazine—Erythema—Dexamethasone—ankylosing spondylitis	0.00315	0.0051	CcSEcCtD
Thioridazine—Erythema—Betamethasone—ankylosing spondylitis	0.00315	0.0051	CcSEcCtD
Thioridazine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00312	0.00506	CcSEcCtD
Thioridazine—Oedema—Prednisolone—ankylosing spondylitis	0.00308	0.00499	CcSEcCtD
Thioridazine—Tachycardia—Prednisolone—ankylosing spondylitis	0.003	0.00487	CcSEcCtD
Thioridazine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.003	0.00486	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00298	0.00482	CcSEcCtD
Thioridazine—Drowsiness—Methotrexate—ankylosing spondylitis	0.00293	0.00475	CcSEcCtD
Thioridazine—Angioedema—Betamethasone—ankylosing spondylitis	0.00288	0.00466	CcSEcCtD
Thioridazine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00288	0.00466	CcSEcCtD
Thioridazine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00285	0.00462	CcSEcCtD
Thioridazine—Oedema—Triamcinolone—ankylosing spondylitis	0.00283	0.00459	CcSEcCtD
Thioridazine—Arrhythmia—Prednisone—ankylosing spondylitis	0.00281	0.00456	CcSEcCtD
Thioridazine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00276	0.00448	CcSEcCtD
Thioridazine—Mental disorder—Prednisone—ankylosing spondylitis	0.00276	0.00447	CcSEcCtD
Thioridazine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00276	0.00447	CcSEcCtD
Thioridazine—Erythema—Prednisone—ankylosing spondylitis	0.00274	0.00444	CcSEcCtD
Thioridazine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00274	0.00444	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00273	0.00443	CcSEcCtD
Thioridazine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00273	0.00443	CcSEcCtD
Thioridazine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00264	0.00428	CcSEcCtD
Thioridazine—Vision blurred—Prednisone—ankylosing spondylitis	0.00258	0.00419	CcSEcCtD
Thioridazine—Oedema—Betamethasone—ankylosing spondylitis	0.00257	0.00416	CcSEcCtD
Thioridazine—Oedema—Dexamethasone—ankylosing spondylitis	0.00257	0.00416	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00254	0.00411	CcSEcCtD
Thioridazine—Anaemia—Prednisone—ankylosing spondylitis	0.00253	0.00411	CcSEcCtD
Thioridazine—Agitation—Prednisone—ankylosing spondylitis	0.00252	0.00408	CcSEcCtD
Thioridazine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00251	0.00408	CcSEcCtD
Thioridazine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00251	0.00408	CcSEcCtD
Thioridazine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00251	0.00406	CcSEcCtD
Thioridazine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00251	0.00406	CcSEcCtD
Thioridazine—Angioedema—Prednisone—ankylosing spondylitis	0.0025	0.00406	CcSEcCtD
Thioridazine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00248	0.00403	CcSEcCtD
Thioridazine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00248	0.00403	CcSEcCtD
Thioridazine—Anorexia—Betamethasone—ankylosing spondylitis	0.00245	0.00397	CcSEcCtD
Thioridazine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00245	0.00397	CcSEcCtD
Thioridazine—Hypotension—Dexamethasone—ankylosing spondylitis	0.0024	0.00389	CcSEcCtD
Thioridazine—Hypotension—Betamethasone—ankylosing spondylitis	0.0024	0.00389	CcSEcCtD
Thioridazine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00233	0.00378	CcSEcCtD
Thioridazine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00233	0.00377	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—ankylosing spondylitis	0.0023	0.00374	CcSEcCtD
Thioridazine—Erythema—Methotrexate—ankylosing spondylitis	0.00229	0.00371	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00227	0.00368	CcSEcCtD
Thioridazine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00224	0.00363	CcSEcCtD
Thioridazine—Oedema—Prednisone—ankylosing spondylitis	0.00224	0.00363	CcSEcCtD
Thioridazine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00223	0.00362	CcSEcCtD
Thioridazine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00223	0.00362	CcSEcCtD
Thioridazine—Tachycardia—Prednisone—ankylosing spondylitis	0.00218	0.00354	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00216	0.00351	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00216	0.0035	CcSEcCtD
Thioridazine—Anorexia—Prednisone—ankylosing spondylitis	0.00213	0.00346	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—ankylosing spondylitis	0.00212	0.00343	CcSEcCtD
Thioridazine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00212	0.00343	CcSEcCtD
Thioridazine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00212	0.00343	CcSEcCtD
Thioridazine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00209	0.00338	CcSEcCtD
Thioridazine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00208	0.00337	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00205	0.00332	CcSEcCtD
Thioridazine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00203	0.00329	CcSEcCtD
Thioridazine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00203	0.00329	CcSEcCtD
Thioridazine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00194	0.00315	CcSEcCtD
Thioridazine—Rash—Prednisolone—ankylosing spondylitis	0.00194	0.00315	CcSEcCtD
Thioridazine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00194	0.00314	CcSEcCtD
Thioridazine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00193	0.00313	CcSEcCtD
Thioridazine—Headache—Prednisolone—ankylosing spondylitis	0.00193	0.00313	CcSEcCtD
Thioridazine—Constipation—Prednisone—ankylosing spondylitis	0.00191	0.0031	CcSEcCtD
Thioridazine—Confusional state—Methotrexate—ankylosing spondylitis	0.00188	0.00306	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00184	0.00299	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00183	0.00297	CcSEcCtD
Thioridazine—Nausea—Prednisolone—ankylosing spondylitis	0.00183	0.00296	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00181	0.00293	CcSEcCtD
Thioridazine—Vomiting—Triamcinolone—ankylosing spondylitis	0.0018	0.00292	CcSEcCtD
Thioridazine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.0018	0.00291	CcSEcCtD
Thioridazine—Rash—Triamcinolone—ankylosing spondylitis	0.00178	0.00289	CcSEcCtD
Thioridazine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00178	0.00289	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—ankylosing spondylitis	0.00178	0.00289	CcSEcCtD
Thioridazine—Rash—Methylprednisolone—ankylosing spondylitis	0.00178	0.00289	CcSEcCtD
Thioridazine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00178	0.00288	CcSEcCtD
Thioridazine—Headache—Triamcinolone—ankylosing spondylitis	0.00177	0.00287	CcSEcCtD
Thioridazine—Headache—Methylprednisolone—ankylosing spondylitis	0.00177	0.00287	CcSEcCtD
Thioridazine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00177	0.00287	CcSEcCtD
Thioridazine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00176	0.00285	CcSEcCtD
Thioridazine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00176	0.00285	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—ankylosing spondylitis	0.00175	0.00283	CcSEcCtD
Thioridazine—Nausea—Triamcinolone—ankylosing spondylitis	0.00168	0.00273	CcSEcCtD
Thioridazine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00168	0.00272	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—ankylosing spondylitis	0.00166	0.00269	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00165	0.00267	CcSEcCtD
Thioridazine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00163	0.00265	CcSEcCtD
Thioridazine—Vomiting—Betamethasone—ankylosing spondylitis	0.00163	0.00265	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00162	0.00263	CcSEcCtD
Thioridazine—Rash—Dexamethasone—ankylosing spondylitis	0.00162	0.00263	CcSEcCtD
Thioridazine—Rash—Betamethasone—ankylosing spondylitis	0.00162	0.00263	CcSEcCtD
Thioridazine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00162	0.00262	CcSEcCtD
Thioridazine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00162	0.00262	CcSEcCtD
Thioridazine—Headache—Dexamethasone—ankylosing spondylitis	0.00161	0.00261	CcSEcCtD
Thioridazine—Headache—Betamethasone—ankylosing spondylitis	0.00161	0.00261	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00154	0.0025	CcSEcCtD
Thioridazine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00153	0.00248	CcSEcCtD
Thioridazine—Nausea—Dexamethasone—ankylosing spondylitis	0.00153	0.00247	CcSEcCtD
Thioridazine—Nausea—Betamethasone—ankylosing spondylitis	0.00153	0.00247	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00148	0.0024	CcSEcCtD
Thioridazine—Vomiting—Prednisone—ankylosing spondylitis	0.00142	0.00231	CcSEcCtD
Thioridazine—Rash—Prednisone—ankylosing spondylitis	0.00141	0.00229	CcSEcCtD
Thioridazine—Dermatitis—Prednisone—ankylosing spondylitis	0.00141	0.00228	CcSEcCtD
Thioridazine—Headache—Prednisone—ankylosing spondylitis	0.0014	0.00227	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00138	0.00223	CcSEcCtD
Thioridazine—Nausea—Prednisone—ankylosing spondylitis	0.00133	0.00215	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00128	0.00207	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—ankylosing spondylitis	0.00119	0.00193	CcSEcCtD
Thioridazine—Rash—Methotrexate—ankylosing spondylitis	0.00118	0.00191	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—ankylosing spondylitis	0.00118	0.00191	CcSEcCtD
Thioridazine—Headache—Methotrexate—ankylosing spondylitis	0.00117	0.0019	CcSEcCtD
Thioridazine—Nausea—Methotrexate—ankylosing spondylitis	0.00111	0.0018	CcSEcCtD
